Study summary · research use only
Humanin signal for Alzheimer's disease
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review discusses humanin, a bioactive peptide proposed to inhibit neuronal death and dysfunction associated with human Alzheimer's disease (AD) by binding a Humanin receptor and activating a STAT3-mediated signal. It cites recent studies reporting that Humanin signaling is decreased in neurons of AD patients, and suggests that restoring or activating Humanin signaling in neurons could be studied as a way of influencing AD disease course, framing this as a research hypothesis rather than an established outcome.
Abstract
Despite a bulk of evidence supporting the idea that increased neurotoxic insults lead to Alzheimer's disease (AD), the possibility still remains that insufficiency of an endogenous defense system contributes to the disease progression. Humanin is a bioactive peptide that is likely to inhibit both neuronal death and dysfunction only related to AD by binding to a Humanin receptor on the cell-surface and by activating a STAT3-mediated signal, preventing the onset of dementia. A couple of recent studies presented evidence suggesting that the Humanin signal is decreased in neurons of AD patients. If this is the case, the restoration or activation of the Humanin signal in neurons may change the course of AD.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.